Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Abstract
Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 36 tables and 76 figures, this 149-page report “Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Software

Based on Omics Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single Cell Genomics (SCG)
•Single Cell Transcriptomics (SCT)
•Single Cell Proteomics (SCP)
•Single Cell Metabolomics (SCM)

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Research
oOncology
oCell Therapy
oImmunology
oNeurology
oCell Biology
oOther Types of Clinical Research
•Translation Research
•Synthetic Biology

By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Human Samples
oCancer Tissues
oStem Cells
oImmune Cells
oBrain Cells
oOther Human Samples
•Animal Samples
•Microbial Samples

By Workflow, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single-Cell Isolation and Dispensing
oFluorescence-Activated Cell Sorting (FACS)
oMicrofluidics
oMagnetic-Activated Cell Sorting (MACS)
oRandom Seeding
oManual Cell Picking
oLaser Capture Microdissection
oOther Technologies of Single-Cell Isolation and Dispensing
•Single-Cell Analysis
oPolymerase Chain Reaction
oNext-Generation Sequencing
oMass Cytometry
oMass Spectrometry
oOther Technologies of Single-Cell Analysis

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Research and Academic Laboratories
•Biopharmaceutical and Biotech Companies
•Contract Research Organizations (CROs)
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Content
Table of Contents

1 Introduction8
1.1 Industry Definition and Research Scope8
1.1.1 Industry Definition8
1.1.2 Research Scope9
1.2 Research Methodology12
1.2.1 Overview of Market Research Methodology12
1.2.2 Market Assumption13
1.2.3 Secondary Data13
1.2.4 Primary Data13
1.2.5 Data Filtration and Model Design14
1.2.6 Market Size/Share Estimation15
1.2.7 Research Limitations16
1.3 Executive Summary17
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market25
2.2 Major Growth Drivers27
2.3 Market Restraints and Challenges35
2.4 Emerging Opportunities and Market Trends38
2.5 Porter’s Fiver Forces Analysis42
3 Segmentation of Asia Pacific Market by Product Type46
3.1 Market Overview by Product Type46
3.2 Instruments48
3.3 Consumables49
3.4 Software50
4 Segmentation of Asia Pacific Market by Omics Type51
4.1 Market Overview by Omics Type51
4.2 Single Cell Genomics (SCG)53
4.3 Single Cell Transcriptomics (SCT)54
4.4 Single Cell Proteomics (SCP)55
4.5 Single Cell Metabolomics (SCM)56
5 Segmentation of Asia Pacific Market by Application57
5.1 Market Overview by Application57
5.2 Clinical Research59
5.2.1 Oncology61
5.2.2 Cell Therapy62
5.2.3 Immunology63
5.2.4 Neurology64
5.2.5 Cell Biology65
5.2.6 Other Types of Clinical Research66
5.3 Translation Research67
5.4 Synthetic Biology68
6 Segmentation of Asia Pacific Market by Sample Type69
6.1 Market Overview by Sample Type69
6.2 Human Samples71
6.2.1 Cancer Tissues73
6.2.2 Stem Cells74
6.2.3 Immune Cells75
6.2.4 Brain Cells76
6.2.5 Other Human Samples77
6.3 Animal Samples78
6.4 Microbial Samples79
7 Segmentation of Asia Pacific Market by Workflow80
7.1 Market Overview by Workflow80
7.2 Single-Cell Isolation and Dispensing82
7.2.1 Fluorescence-Activated Cell Sorting (FACS)84
7.2.2 Microfluidics85
7.2.3 Magnetic-Activated Cell Sorting (MACS)86
7.2.4 Random Seeding87
7.2.5 Manual Cell Picking88
7.2.6 Laser Capture Microdissection89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing90
7.3 Single-Cell Analysis91
7.3.1 Polymerase Chain Reaction93
7.3.2 Next-Generation Sequencing94
7.3.3 Mass Cytometry95
7.3.4 Mass Spectrometry96
7.3.5 Other Technologies of Single-Cell Analysis97
8 Segmentation of Asia Pacific Market by End User98
8.1 Market Overview by End User98
8.2 Research and Academic Laboratories100
8.3 Biopharmaceutical and Biotech Companies101
8.4 Contract Research Organizations (CROs)102
8.5 Other End Users103
9 Asia-Pacific Market 2021-2031 by Country104
9.1 Overview of Asia-Pacific Market104
9.2 Japan107
9.3 China110
9.4 Australia112
9.5 India114
9.6 South Korea116
9.7 Rest of APAC Region118
10 Competitive Landscape120
10.1 Overview of Key Vendors120
10.2 New Product Launch, Partnership, Investment, and M&A123
10.3 Company Profiles124
10x Genomics, Inc.124
1CellBio, Inc.126
Becton, Dickinson and Company127
Berkeley Lights, Inc.128
BGI Genomics Co., Ltd.129
Bio-Rad Laboratories, Inc.130
Bio-Techne Corporation131
BioTuring, Inc.132
Danaher Corporation (Cytiva Life Sciences)133
Dolomite Bio134
Fluidigm Corporation135
Fluxion Biosciences136
Illimina, Inc137
Mission Bio, Inc.138
Namocell, Inc.139
NanoString Technologies, Inc.140
Parse Biosciences, Inc.141
Proteona142
Qiagen N.V.143
RareCyte, Inc.144
Scipio Biosciences SAS145
Shilps Sciences146
Takara Bio Inc. (Takara Holdings)147
Thermo Fisher Scientific Inc.148
RELATED REPORTS149

List of Figures:

Figure 1. Research Method Flow Chart12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-203117
Figure 4. Asia Pacific Single Cell Multiomics Market, 2021-2031, $ mn20
Figure 5. Impact of COVID-19 on Business25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Single Cell Multiomics Market27
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-201931
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million33
Figure 10. World Population 65 and Over, % of Total Population, 1950-206033
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Single Cell Multiomics Market35
Figure 12. Investment Opportunity Analysis39
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Single Cell Multiomics Market42
Figure 14. Breakdown of Asia Pacific Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue47
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)47
Figure 16. Asia Pacific Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn48
Figure 17. Asia Pacific Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn49
Figure 18. Asia Pacific Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn50
Figure 19. Breakdown of Asia Pacific Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue52
Figure 20. Asia Pacific Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)52
Figure 21. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn53
Figure 22. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn54
Figure 23. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn55
Figure 24. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn56
Figure 25. Breakdown of Asia Pacific Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue58
Figure 26. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)58
Figure 27. Asia Pacific Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn59
Figure 28. Asia Pacific Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn61
Figure 29. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn62
Figure 30. Asia Pacific Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn63
Figure 31. Asia Pacific Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn64
Figure 32. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn65
Figure 33. Asia Pacific Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn66
Figure 34. Asia Pacific Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn67
Figure 35. Asia Pacific Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn68
Figure 36. Breakdown of Asia Pacific Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue70
Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)70
Figure 38. Asia Pacific Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn71
Figure 39. Asia Pacific Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn73
Figure 40. Asia Pacific Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn74
Figure 41. Asia Pacific Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn75
Figure 42. Asia Pacific Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn76
Figure 43. Asia Pacific Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn77
Figure 44. Asia Pacific Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn78
Figure 45. Asia Pacific Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn79
Figure 46. Breakdown of Asia Pacific Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue81
Figure 47. Asia Pacific Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)81
Figure 48. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn82
Figure 49. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn84
Figure 50. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn85
Figure 51. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn86
Figure 52. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn87
Figure 53. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn88
Figure 54. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn89
Figure 55. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn90
Figure 56. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn91
Figure 57. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn93
Figure 58. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn94
Figure 59. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn95
Figure 60. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn96
Figure 61. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn97
Figure 62. Breakdown of Asia Pacific Single Cell Multiomics Market by End User, 2021-2031, % of Revenue98
Figure 63. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)99
Figure 64. Asia Pacific Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn100
Figure 65. Asia Pacific Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn101
Figure 66. Asia Pacific Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn102
Figure 67. Asia Pacific Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn103
Figure 68. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue105
Figure 69. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)106
Figure 70. Single Cell Multiomics Market in Japan, 2021-2031, $ mn108
Figure 71. Single Cell Multiomics Market in China, 2021-2031, $ mn110
Figure 72. Single Cell Multiomics Market in Australia, 2021-2031, $ mn112
Figure 73. Single Cell Multiomics Market in India, 2021-2031, $ mn114
Figure 74. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn116
Figure 75. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn118
Figure 76. Growth Stage of Asia Pacific Single Cell Multiomics Industry over the Forecast Period120